Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
Clinical Cancer Research, 08/21/2012
Bae J et al. – The results highlight the potential therapeutic application of vaccination with a cocktail of HLA–A2–specific peptides to induce cytotoxic T lymphocytes (CTL) with a broad spectrum of immune responses against multiple myeloma antigens.



